The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The ASX200 is set to open 0.46% higher today, reflecting a mixed night on the US stock market, after the release of inflation figures which matched expectations.

All three of Wall Street’s main indices were nearly flat by the end of the night: the S&P 500 rose slightly, the Dow moved up 47 points or 0.1%, and the Nasdaq was 0.2% lower. The Consumer Price Index rose 2.6% year-over-year, with core inflation at 3.3%: both of these results being in-line with expectations. This bolstered the likelihood that the Federal Reserve will cut rates in December, with CME FedWatch showing an 80% chance of this.

On the ASX, mining services and infrastructure solutions provider Orica Ltd (ASX:ORI) said its profit for the 2024 fiscal year had come in at $525 million, while its earnings before interest and tax were $806 million – a rise of 15% from the previous year. Orica reported an unfranked final dividend of 28 cents per share.

And De Grey Mining Ltd (ASX:DEG) said the mineral resource estimate (MRE) at its Hemi Gold Project in Western Australia had risen by 0.7 million ounces (Moz) to 11.2Moz, based on drilling conducted since November 2023.

To commodities – all in US $ here: Iron ore is $102.96 on the Singapore Exchange, gold’s trading at $2576, Brent crude is $71.92 & natural gas is $2.99 a gigajoule.

One Aussie dollar is buying just under 65 US cents.

Join the discussion: See what’s trending right now on Australia’s largest stock forum and be part of the conversations that move the markets.

More From The Market Online
Market Close Graphic

ASX Market Close: Another reversal as just-green Oz markets ignore US dive | Jan 3, 2024

The Aussie bourse has defied morning expectations for the second time in as many days, closing out all but flat with a 0.
A Red Sky Energy rig out in the ocean.

Red Sky Energy bleeds more than 18% after ‘landmark’ Angola block entry

Red Sky Energy was ready to pop champagne after being awarded 35% in a "transformative" Angola…
A patient being dosed with Imugene Limited testing materials.

First Aussie doses bring Imugene major step closer to ‘quicker, cheaper’ non-Hodgkin’s lymphoma care

Imugene Limited (ASX:IMU) has hit its first important milestone in 2025, dosing its first Australian patient with its allogenic
A market trading board with ASX marked on the side.

‘Shine a light’: ASX to get more aggressive on companies ‘not up to scratch’ on disclosures

The Australian Securities Exchange (ASX:ASX) will be taking poor disclosure from market-listed companies far more seriously through this next